TYLECO SOLUBLE WATER SOLUBLE TYLOSIN TARTRATE

Pays: Australie

Langue: anglais

Source: APVMA (Australian Pesticides and Veterinary Medicines Authority)

Ingrédients actifs:

TYLOSIN AS TARTRATE

Disponible depuis:

INTERNATIONAL ANIMAL HEALTH PRODUCTS PTY LTD

DCI (Dénomination commune internationale):

tylosin as tartrate(800mg/g)

forme pharmaceutique:

ORAL POWDER, PRE-MIX

Composition:

TYLOSIN AS TARTRATE ANTIBIOTIC Active 800.0 mg/g

Unités en paquet:

100g; 10kg; 1kg

classe:

VM - Veterinary Medicine

Fabriqué par:

IAHP

Groupe thérapeutique:

PIGS | POULTRY BROILERS (MEAT FOR HUMAN CONSUM) | PULLET - REPLACEMENT | TURKEYS | BOAR | BREEDER | BROILER BREEDER | CHICKENS |

Domaine thérapeutique:

ANTIBIOTIC & RELATED

indications thérapeutiques:

MYCOPLASMA GALLISEPTICUM | SWINE DYSENTERY | CHRONIC RESPIRATORY DISEASE (C | INFECTIOUS SINUSITIS

Descriptif du produit:

Poison schedule: 4; Withholding period: WHP: MEAT: Nil. WHP: EGGS: Do not use in bird which are producing or may in the future produce eggs or egg products for human consumption. ESI: This prod uct does not have an ESI established. F or advice on the ESI, contact the manuf acturer on 02)9672 7944 before using th is product.; Host/pest details: PIGS: [SWINE DYSENTERY]; POULTRY BROILERS (MEAT FOR HUMAN CONSUM): [MYCOPLASMA GALLISEPTICUM]; PULLET - REPLACEMENT: [MYCOPLASMA GALLISEPTICUM]; TURKEYS: [MYCOPLASMA GALLISEPTICUM]; Poison schedule: 4; Withholding period: ; Host/pest details: PIGS: [SWINE DYSENTERY]; POULTRY BROILERS (MEAT FOR HUMAN CONSUM): [MYCOPLASMA GALLISEPTICUM]; PULLET - REPLACEMENT: [MYCOPLASMA GALLISEPTICUM]; TURKEYS: [MYCOPLASMA GALLISEPTICUM]; As an aid in the control and treatment of chronic respiratory disease (CRD) in broilers and replacement chickens, and infectious sinusitis in turkeys. As an aid in the prevention and treatment of swine dysentery in pigs.DO NOT USE in laying hens, or in replacement pullets/broiler breeders within 7 days of the onset of lay, where eggs or egg products are to be used for human consumption or processing.

Statut de autorisation:

Registered

Date de l'autorisation:

2023-07-01

Notice patient

CONDITIONS OF SALE Thrs product
IS
sold on the express condition that It must
be
used stncfly
In
accordance Withthe manufacturer's instruction for use. No warranty,
whether expressed or
Implied
,
given for any and all damages, which may anse for goods not used In
accordanceWith the
manufacturer's instructions
DIRECTIONS FOR USE:
Re
strain
ts : DO NOT USE in laying hens , or in repl acem
ent
pull
ets/broiler
breeders
with
in 7
days
of
the
onset
of
lay ,
wh
er e
eggs
or
egg
products
are to be
used
for
human consumpt ion or
proc
essing
.
Blend TYLEC O
TM
SOLUBLE at a rate of 100 g into 5 L warm water and
mix
thoroughly. Dilute the concentrnted solution to prepare a recommended
dose rate. Alway s add the wa ter to the powder and prepare a fresh
TYLECO SOLUBLE solution every three days
Dosage and
Administration
:
CHICKENS
&
TURKEYS:
Dilute the concentrated solution to make up to 200 L
of
medicated drink
09
water.
Provide as the only source of dnnking wat er. This is suffiCient f
t
e
treatment
of 1.400 broilers for 4 days (or 0.018g1blrd/day ) or 2,800 da
chickens for 3 day s (or 0.012g/bird/day) or 2,800 chickens
of
age
18 and 24 days for
lday
(or
00
35g/bird/day)
CHICKENS: As an aid in the
Control
and
TreatmeMof
CIlf\
I
Respiratory
Disease
(CRD)
in
Broilers
and Replaceme
nf
Gl1
caused by
Mycoplasma
gallisepticum
.
_Prevention :_
Treat chicken s for the first
3 days
of
life .
iii
n
for one day at 3 to 4 weeks
of
age
or
In eve
vaccination and any other stress
_Treatment:_
Thoroughly mix 0 .5 g tylos in activ ity
wi
tylosin activity per 200 L). Use only T
wat er for 3 to 6 days depending on
th,""...
,....,.
.......
,
TURKEYS: As an aid in
the
control
and Treatment'
I~S
caused
by
M.
gallisepticum
.
Use only TYLECO SOLUBL E medicated water for
2
to 5
~
a
on the seventy
of
inf ection
E!Q§
:
As an aid in
the
prevention
and
treatment
of
sw
ne
Dilute the concentrated solution to make up to
400
L
of
medica
w ater
Thor oughly mix 0 20 g
(200
mg)
tylOSin
actiVity with
08
water (100 g tylo sin activity per 400 L). Treat for 3 to

Résumé des caractéristiques du produit

G:1ah\MSDS Info:Tyleco Soluble
IAH SALES PTY LTD
A.B.N. 57 109 433 883
18 HEALEY CIRCUIT, HUNTINGWOOD NSW 2148
TELEPHONE [phone] FAX. [phone]
Page 1 of 4
Issued: May 2007
MATERIAL SAFETY DATA SHEET
NOT CLASSIFIED AS HAZARDOUS ACCORDING TO CRITERIA OF WORKSAFE
AUSTRALIA
PRODUCT IDENTIFICATION
PRODUCT NAME
:
TYLECO™ SOLUBLE
CAS NUMBER
:
1405-54-5 (Tylosin tartrate)
UN NUMBER
:
None Allocated
DG CLASS
:
None Allocated
HAZCHEM
:
None Allocated
SUBRISK
:
None Allocated
PACKAGING GROUP
:
None Allocated
POISONS SCHEDULE
:
Schedule 4 (Prescription Animal Remedy)
USE
:
Control and treatment of Chronic Respiratory Disease (CRD) in broilers
and
replacement chickens, and infectious sinusitis in turkeys. Prevention
and
treatment of Swine Dysentery in pigs.
PHYSICAL DESCRIPTION/PROPERTIES:
APPEARANCE
:
Light to medium yellow granular powder with specific odor.
BULK DENSITY
:
0.96 - 1.04 gm/mL
FLASH POINT
:
No data
BOILING POINT
:
No data
FLAMMABILITY LIMITS
:
1. Lower Explosive Limit (LEL) – no ignition up to 0.605 oz/cu ft.
2. Upper Explosive Limit (UEL) – not established
VAPOR PRESSURE
:
No data
SOLUBILITY
:
Very
soluble in water, soluble in absolute alcohol
PAGE 2 OF 4:
MSDS SHEET/TYLECO™ SOLUBLE
May 2007
NOT CLASSIFIED AS HAZARDOUS ACCORDING TO CRITERIA OF WORKSAFE
AUSTRALIA
INGREDIENTS: CAS NO. PROPORTION
Tylosin A tartrate
1405-54-5
1000.0 g/kg
(11E,13E)-(4R,5S,6S,7R.9R,15R,16R)-15-{[(6-deoxy-2,3-di-O-methyl-ß-D-allopyranosyl)oxy]methyl}-
6-{[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-a-L-ribohexopyranosil)-
3-(dimethylamino)-ß-
D-glucopyranosyl]oxy}-16-ethyl-4-
hydroxy-5,9,13-trimethyl-7-(2-oxoethyl) oxacyclohexadeca-
11,13-diene-2,10-dione
HEALTH HAZARD INFORMATION
ACUTE EFFECTS: (ANIMALS)
EYE
:
Irritant (Rabbit).
SKIN
:
May be slightly irritant to the skin, but no toxicity and deaths
reported (Rabbit).
INHALED
:
No information available on inhalation studies.
SWALLOWED
:
No toxicity and deaths reported from studies in rats.
CHRONIC EFFECTS: (ANIMALS)
TARGET ORGAN
EFFECT
:
No applicable information f